# Primary Irritation Patch Test (PIPT) Study Conducted at NovoBliss Research for Shared Panel

> **NCT05642702** · NA · UNKNOWN · sponsor: **NovoBliss Research Pvt Ltd** · enrollment: 26 (estimated)

## Conditions studied

- Healthy

## Interventions

- **OTHER:** Peptide complexed HA Age Defying Gel with Vitamin C & Niacinamide
- **OTHER:** Peptide complexed HA Age Defying Gel with Natural Extracts
- **OTHER:** Peptide complexed HA Age Defying Gel with Vitamin C & Natural Extracts
- **OTHER:** 1% w/v Sodium Lauryl Sulphate (SLS) solution
- **OTHER:** Sodium chloride (Isotonic Saline Solution) Injection IP 0.9 % w/v

## Key facts

- **NCT ID:** NCT05642702
- **Lead sponsor:** NovoBliss Research Pvt Ltd
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-05
- **Primary completion:** 2022-12-13
- **Final completion:** 2022-12-20
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2022-12-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05642702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05642702, "Primary Irritation Patch Test (PIPT) Study Conducted at NovoBliss Research for Shared Panel". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05642702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*